During the review, the committee will likely consider: The extensive body of published research on GHK-Cu (decades of studies) Safety data for both injectable and topical routes The clinical rationale for copper peptide therapy in anti-aging and wound healing Quality control considerations for compounding GHK-Cu formulations Public comments from patients, dermatologists, anti-aging practitioners, and pharmacies Given GHK-Cu's long history of use and substantial research base, many in the peptide therapy community are cautiously optimistic about a positive PCAC recommendation particularly for the topical route
Wound healing, cellular regeneration and plasticity: The elegans way
This is also the point where people often take stock of how they feel compared to when they started
They are being investigated for a wide range of diseases, including cancer [4], metabolic disorders [5], autoimmune conditions [6], and wound healing [7, 8]
Maksymalne korzyci stosowania GHK-Cu osigane s zwykle po 12-16 tygodniach cigej terapii, kiedy procesy regeneracyjne stabilizuj si na wysokim poziomie
